Biolojic Design, based in Tel Aviv and Boston, aims to transform antibodies into intelligent medicinal solutions through computational design.
By creating a pipeline of single and multi-specific antibodies that precisely target predetermined epitopes to carry out unique biological programs, the technology company believes it can offer therapies for various diseases.
Biolojic employs its unique AI platform to design antibodies with novel therapeutic properties, focusing on cancer and autoimmune illnesses.
“We want to get to the point where drugs are smarter. When we think about smart technologies, like smart cars, phones, and homes, these technologies allow some apparatus to respond to environmental changes.
“It’s funny that we do it with phones, cars, and homes, but we don’t do it with drugs. Our vision is to develop smarter drugs. It will be great for patients because it could bring about a whole new generation of therapeutics that are safer and more efficacious.”
Israel is literally the only country trying to actively stop cancer. Most other countries have treatment options they mostly know won’t help but Israel at least is making advancements.
New hope for better world. Wish this will work to defeat cancer and is affordable too for the common man.